VUZE Medical was incorporated in 2017 in Israel and is financed privately. Milestones so far include high accuracy and speed on an anatomical model (2018) and in cadaver surgeries (2019-2020), a first US Patent (2020, with five more since), first European and Asian patents (2021), FDA 510(k) submission (2021), successful first-in-human surgery (late 2021), FDA 510(k) clearance for minimally-invasive thoracolumbar fixation and augmentation (2022), the completion of a highly-successful twenty-patient clinical trial (early 2023) and cadaveric proofs of concept for pain therapy and open surgery (mid 2023).
Extensive Experience and a Strong Track Record
A veteran team brings strong domain expertise in adding computer guidance to common manual interventions. Our two prior endeavors have each become a Standard of Care in its respective field: superDimension (now Medtronic) in bronchoscopies with 1,000 installations worldwide, and SyncVision (now Philips) in coronary catheterizations with 4,000 installations worldwide.
left to right:
Sasha Steinberg algorithms
Sigi Elazar UI & UX
Rivay Mor algorithms
Koby Zakaeim application engineering
Neta Stern software
Yoav Stein software
Levona Schriger testing & support
Asaf Omer QA & RA
Ran Cohen CTO
David Tolkowsky CEO
Copyright © 2023 VUZE Medical Ltd. All rights reserved. Proprietary. Patents granted. Patents pending. The VUZE system, VUZE software and Dynamic Online Image Registration (DOLIR) are trademarks of VUZE Medical.